The Middle East and Africa cell sorting market size is estimated to grow at a CAGR of 3.03% between 2023 to 2028. This regional market was worth USD 17.68 million in 2024 and grow to USD 20.53 million by 2029.
The growing prevalence of cancer and HIV cases across the Middle East and African countries majorly propels the cell sorting market in the MEA region. Cancer stands as the foremost cause of mortality in the region, with Egypt reporting approximately 134,632 new cancer cases in 2018 alone. This concerning statistic highlights the need for effective measures to combat various cancer types such as breast cancer, lung cancer, skin cancer, brain cancer, and more. Lifestyle changes, increased alcohol and tobacco consumption, hormonal shifts, and genetic factors contribute significantly to the incidence of cancer within the population. Early detection of cancer plays a crucial role in improving an individual's life expectancy and quality of life. In this context, cell sorting techniques prove invaluable as they facilitate the separation of specific cell types from a sample, aiding in the determination of cancer severity and enabling tailored administration of appropriate cancer treatments.
The growing adoption of cell sorting techniques in research and development activities further favors the cell sorting market in the MEA region. Researchers have been increasingly focussing on developing novel drugs to prevent or cure chronic diseases, which necessitates the utilization of cell sorting methodologies. To enhance drug efficacy and reduce side effects, an increasing number of clinical trials are being conducted, further driving the need for cell sorting. Additionally, researchers are actively engaged in developing advanced cell sorting techniques to improve the speed and efficiency of cell separation across diverse cell groups. The regional market is also fueled by substantial investments from public, private, and healthcare organizations, along with the cost advantage offered by cell sorting techniques compared to other methodologies.
The growing number of advancements in stem cell research, increasing demand for personalized medicine, rising number of initiatives and funding support by the governments of MEA countries, technological advancements in cell sorting techniques and growing number of collaborations between academic institutions and industry players contribute to the MEA cell sorting market growth. Expansion of healthcare infrastructure. The rising awareness about the benefits of cell sorting and increasing investments by pharmaceutical and biotechnology companies in the MEA region propel the MEA cell sorting market growth.
Limited infrastructure for advanced cell sorting technologies, lack of skilled professionals in the field of cell sorting and stringent regulatory policies and compliance requirements primarily hamper the cell sorting market growth in the MEA region. High cost associated with cell sorting instruments and consumables, poor awareness and understanding of cell sorting technologies, lack of funding and investments for research and development and challenges in integrating cell sorting technologies into existing healthcare systems further impedes the regional market growth.
This research report on the Middle East & Africa cell sorting market has been segmented and sub-segmented into the following categories.
By Technology:
By Product:
By Application:
By End-User:
By Country:
Based on the region, the Middle East and Africa market accounted for a share of 8% of the global market in 2022. During the forecast period, the cell sorting market in the Middle East and Africa region has increased healthcare infrastructure as a significant driving factor. This region is also focusing on expanding the usage of cell sorting in various types of applications. Additionally, the increment of cancer cases and HIV in the Middle East and Africa region. Replacement of sales, demographics of countries, data points like new sales, and regulation of acts are also significant drivers of the Middle East and Africa region.
KEY MARKET PLAYERS:
Becton Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sony Biotechnology, Inc. (U.S.), Sysmex Partec GmbH (Japan), Cytonome/ST, LLC (U.S.), On-Chip Biotechnologies Co., Ltd. (Japan), and Union Biometrica, Inc. (U.S.) are a few of the notable companies in the MEA cell sorting market.
Frequently Asked Questions
Saudi Arabia and Egypt are predicted to have considerable growth in the MEA market.
The regulatory policies and compliance requirements for cell sorting technologies in the MEA region may vary among different countries and can include aspects related to safety, efficacy, and ethical considerations. Specific details are not provided.
Emerging trends and opportunities in the cell sorting market in the MEA region may include the development of novel sorting techniques, increasing collaborations between research institutions and industry players, and the integration of cell sorting technologies into clinical settings for improved patient care.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region